The Effects of Folic Acid Supplementation on Plasma Total Homocysteine Are Modulated by Multivitamin Use and Methylenetetrahydrofolate Reductase Genotypes
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (6), 1157-1162
- https://doi.org/10.1161/01.atv.17.6.1157
Abstract
Elevated concentration of plasma total homocysteine (tHcy) is a common risk factor for arterial occlusive diseases. Folic acid (FA) supplementation usually lowers tHcy levels, but initial ...Keywords
This publication has 10 references indexed in Scilit:
- Homocysteine and coronary atherosclerosisJournal of the American College of Cardiology, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Plasma homocysteine in acute myocardial infarction: homocysteine-lowering effect of folic acidJournal of Internal Medicine, 1995
- Advances in understanding and novel therapeutic targets in inflammatory arthritisIrish Journal of Medical Science, 1995
- Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjectsJournal of Internal Medicine, 1994
- Vitamin Requirements for the Treatment of Hyperhomocysteinemia in HumansJournal of Nutrition, 1994
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identificationNature Genetics, 1994
- Homocyst(e)inemia in daily practiceCoronary Artery Disease, 1990
- Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineNew England Journal of Medicine, 1983